Synthesis and identification of β-aryloxyquinolines and their pyrano[3,2-c]chromene derivatives as a new class of antimicrobial and antituberculosis agents

European Journal of Medicinal Chemistry

Volumn 46, Issue 9, 2011, Pages 4192-4200

  Mungra, Divyesh C ^a   Patel, Manish P ^a   Rajani, Dhanji P ^b   Patel, Ranjan G ^a  

^a SARDAR PATEL UNIVERSITY   (India)

^b Microcare Laboratory   (India)

Author keywords

Aryloxyquinoline; Antimicrobial activity; Antituberculosis activity; Multicomponent reaction; Pyrano 3,2 c chromene

Indexed keywords

2 (4 CHLOROPHENOXY) 6 METHOXYQUINOLINE 3 CARBALDEHYDE; 2 (4 CHLOROPHENOXY) 6 METHYLQUINOLINE 3 CARBALDEHYDE; 2 (4 CHLOROPHENOXY)QUINOLINE 3 CARBALDEHYDE; 2 (4 METHYLPHENOXY)QUINOLINE 3 CARBALDEHYDE; 2 AMINO 5 OXO 4 (2 PHENOXYQUINOLIN 3 YL) 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 (6 METHOXY 2 PHENOXYQUINOLIN 3 YL) 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 (6 METHYL 2 PHENOXYQUINOLIN 3 YL) 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 [2 (4 CHLOROPHENOXY) 6 METHOXYQUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 [2 (4 CHLOROPHENOXY) 6 METHYLQUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 [2 (4 CHLOROPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 [2 (4 METHYLPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 [6 METHOXY 2 (4 METHYLPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 4 [6 METHYL 2 (4 METHYLPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 (2 PHENOXYQUINOLIN 3 YL) 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 (6 METHOXY 2 PHENOXYQUINOLIN 3 YL) 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 (6 METHYL 2 PHENOXYQUINOLIN 3 YL) 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 [2 (4 CHLOROPHENOXY) 6 METHOXYQUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 [2 (4 CHLOROPHENOXY) 6 METHYQUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 [2 (4 CHLOROPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 [2 (4 METHYLPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 [6 METHOXY 2 (4 METHYLPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 AMINO 5 OXO 9 METHYL 4 [6 METHYL 2 (4 METHYLPHENOXY)QUINOLIN 3 YL] 4,5 DIHYDROPYRANO [3,2 C]CHROMENE 3 CARBONITRILE; 2 PHENOXYQUINOLINE 3 CARBALDEHYDE; 6 METHOXY 2 (4 METHYLPHENOXY)QUINOLINE 3 CARBALDEHYDE; 6 METHOXY 2 PHENOXYQUINOLINE 3 CARBALDEHYDE; 6 METHYL 2 (4 METHYLPHENOXY)QUINOLINE 3 CARBALDEHYDE; 6 METHYL 2 PHENOXYQUINOLINE 3 CARBALDEHYDE; ANTIINFECTIVE AGENT; CHROMENE DERIVATIVE; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; BACILLUS SUBTILIS; CANDIDA ALBICANS; CLOSTRIDIUM TETANI; CONTROLLED STUDY; DRUG IDENTIFICATION; DRUG POTENTIATION; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ONE POT SYNTHESIS; SALMONELLA TYPHI; STREPTOCOCCUS PNEUMONIAE; VIBRIO CHOLERAE;

ANTI-INFECTIVE AGENTS; ASPERGILLUS FUMIGATUS; BACTERIA; BENZOPYRANS; CANDIDA ALBICANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; QUINOLINES;

EID: 80052938190     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2011.06.022     Document Type: Article

References (38)

1. N. Woodford Expert Opin. Investig. Drugs 12 2003 117
2. C. Dye, S. Scheele, P. Dolin, V. Pathania, and M.C. Raviglione J. Am. Med. Assoc. 282 1999 677 686
3. T.R. Frieden, T.R. Sterling, S.S. Munsiff, C.J. Watt, and C. Dye Lancet 362 2003 887 899
4. N.K. Ladani, M.P. Patel, and R.G. Patel Ind. J. Chem. Sect. B. 48 2009 261 266
5. N.K. Ladani, M.P. Patel, and R.G. Patel Phosphorus Sulfur Silicon Relat. Elem. 185 2010 658 662
6. N.K. Ladani, M.P. Patel, and R.G. Patel Arkivoc vii 2009 292 302
7. D.C. Mungra, M.P. Patel, and R.G. Patel Arkivoc xiv 2009 64 74
8. D.C. Mungra, M.P. Patel, R.G. Patel, Med. Chem. Res. 20 (2011) 782-789.
9. J.P. Nirmal, M.P. Patel, and R.G. Patel Ind. J. Chem. Sect. B. 48 2009 712 717
10. N.K. Shah, M.P. Patel, and R.G. Patel Phosphorus Sulfur Silicon Relat. Elem. 184 2009 2704 2719
11. N.K. Shah, M.P. Patel, and R.G. Patel Ind. J. Chem. Sect. B. 48 2009 1170 1173
12. N.J. Thumar, M.P. Patel, Arch. Pharm. Chem. Life Sci. 2 (2011) 91-101.
13. A. Mahamoud, J. Chevalier, A. Davin-Regli, J. Barbe, and Jean-Marie Pages Curr. Drug Targets 7 2006 843 847
14. S. Eswaran, A.V. Adhikari, and R.A. Kumar Eur. J. Med. Chem. 45 2010 957 966
15. P. Nasveld, and S. Kitchener Trans. R. Soc. Trop. Med. Hyg. 99 2005 2 5
16. K. Kaur, M. Jain, R.P. Reddy, and R. Jain Eur. J. Med. Chem. 45 2010 3245 3264
17. P.A. Leatham, H.A. Bird, V. Wright, D. Seymour, and A. Gordon Eur. J. Rheumatol. Inflamm. 6 1983 209 211
18. W.A. Denny, W.R. Wilson, D.C. Ware, G.J. Atwell, J.B. Milbank, R.J. Stevenson, U.S Patent, 7064117, 2006.
19. N. Muruganantham, R. Sivakumar, N. Anbalagan, V. Gunasekaran, and J.T. Leonard Biol. Pharm. Bull. 27 2004 1683 1687
20. M.P. Maguire, K.R. Sheets, K. McVety, A.P. Spada, and A. Zilberstein J. Med. Chem. 37 1994 2129 2137
21. W.D. Wilson, M. Zhao, S.E. Patterson, R.L. Wydra, L. Janda, and L. Strekowski Med. Chem. Res. 2 1992 102 110
22. L. Strekowski, J.L. Mokrosz, V.A. Honkan, A. Czarny, M.T. Cegla, S.E. Patterson, R.L. Wydra, and R.F. Schinazi J. Med. Chem. 34 1991 1739 1746
23. R.S. Upadhayaya, G.M. Kulkarni, N.R. Vasireddy, J.K. Vandavasi, S.S. Dixit, V. Sharma, and J. Chattopadhyaya Bioorg. Med. Chem. 17 2009 4681 4692
24. G.R. Green, J.M. Evans, and A.K. Vong A.R. Katritzky, C.W. Rees, E.F. Scriven, Comprehensive Heterocyclic Chemistry II 5 1995 Pergamon Press Oxford 469
25. W.O. Foye Principi Di Chemico Farmaceutic 1991 Piccin Padova, Italy 416
26. M.M. Khafagy, A.H.F.A. El-Wahab, F.A. Eid, and A.M. El-Agrody Farmaco 57 2002 715 722
27. C.P. Dell, C.W. Smith, Eur. Patent Appl. EP537949 Chem. Abstr. 1993, 119, 139102d.
28. G. Bianchi, and A. Tava Agric. Biol. Chem. 51 1987 2001 2002
29. K. Hiramoto, A. Nasuhara, K. Michiloshi, T. Kato, and K. Kikugawa Mutat. Res. 395 1997 47 56
30. S.J. Mohr, M.A. Chirigos, F.S. Fuhrman, and J.W. Pryor Cancer Res. 35 1975 3750 3754
31. W.P. Smith, L.S. Sollis, D.P. Howes, C.P. Cherry, D.I. Starkey, and N.K. Cobley J. Med. Chem. 41 1998 787 797
32. A.G. Martinez, and L.J. Marco Bioorg. Med. Chem. Lett. 7 1997 3165 3170
33. F. Eiden, and F. Denk Arch. Pharm. Weinheim Ger. Arch. Pharm. 324 1991 353 354
34. O. Meth-Cohn, and N.A. Bramha Tetrahedron Lett. 23 1978 2045 2048
35. M. Kidwai, and S. Saxena Synth. Commun. 36 2006 2737 2742
36. NCCLS (National Committee for Clinical Laboratory Standards) Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement 2002 1-56238-454-6, M100-S12(M7)
37. A. Rattan Antimicrobials in Laboratory Medicine, Churchill B I 2000 Livingstone New Delhi 85-108
38. B.S. Furniss, A.J. Hannaford, P.W.G. Smith, and A.R. Tatchell Vogel's Textbook of Practical Organic Chemistry fifth ed. 2004 Longman Harlow